Radiation Dose Management Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Radiation Dose Management Market
The radiation dose management market size was valued at USD 582.2 million in 2023, and the market is now projected to grow from USD 662.9 million in 2024 to USD 1678.5 million by 2032, exhibiting a CAGR of 14.2% during the forecast period of 2024-2032.
The COVID-19 pandemic severely disrupted healthcare offerings, leaving positive areas, particularly CT scans, unaffected. CT scans have been the most commonly used device for COVID-19 analysis because of their better specificity and limitations of RT-PCR. Key players within the marketplace generated giant revenue for their imaging merchandise at some point of the pandemic. Some imaging modalities skilled slow growth, main to marketplace boom. Siemens Healthineers AG saw a 1.7% increase in 2020, as compared to nine.6% in 2019. This accelerated CT scans led hospitals to buy additional systems, increasing income and adoption of these software program. The market completely recovered in 2022 and is predicted to grow notably in the forecast length.
Advancements in technology have prompted radiology manufacturers to develop imaging equipment and software that minimize radiation exposure and improve image quality. Iterative reconstruction algorithms and other image improvement techniques are used globally to reduce radiation requirements for diagnostic-quality images. Software vendors are using advanced versions of existing solutions, such as Affidea's 3.2 version of GE Healthcare's DoseWatch software and a new business intelligence tool. Standardization of imaging protocols ensures consistent radiation use, leading to continuous advancements in imaging technologies and radiation dose management market growth.
Artificial Intelligence (AI) is gaining significant market share in radiology practices due to its potential to optimize imaging protocols and predict individual-specific radiation doses. AI algorithms can enhance image reconstruction techniques and predict death rates from lung cancer and CVD. A recent study published in Radiology showed that AI can use low-dose CT scans to increase risk prediction for lung cancer. As diagnostic imaging technology advances, ongoing research and innovation will enhance software outcomes, leading to the development of new tools and methodologies for monitoring, measuring, and minimizing radiation dose exposure.
Comprehensive Analysis of Radiation Dose Management Market
The global radiation dose management market is divided into various segments, including radiography and mammography, nuclear medicine, oncology, orthopedics, cardiology, and neurology. The radiography and mammography phase is anticipated to develop the maximum due to the increasing use of mammography software and interventional X-ray systems. The nuclear remedy segment is anticipated to grow at the highest CAGR because of the increasing variety of SPECT and PET experiment approaches international. The orthopedics phase is the largest because of the benefits of these merchandise in protective sufferers and surgeons during surgeries. Oncology is projected to check in the very best CAGR due to the growing demand for non-invasive prognosis techniques, which include CT scans. The stop-person phase is segmented into hospitals and area of expertise clinics, diagnostic centers, and others. The diagnostic centers segment held the biggest marketplace percentage in 2022 and is predicted to extend at the very best CAGR at some stage in the forecast period, 2023-2030.
The North America region lead the radiation dose management market share by benefitting a market size of USD 225.7 million in 2023 due to affected person protection guidelines, addressing radiation publicity, and the large wide variety of nuclear medicinal drug techniques inside the U.S., alongside the presence of SPECT cameras.
Siemens Healthineers AG, FUJIFILM Corporation, and GE Healthcare are the top marketplace players in 2022 because of their various product portfolio, robust geographic presence, and huge international purchaser base. Strategic initiatives like acquisitions are predicted to help maintain and consolidate their international marketplace role. Other agencies encompass Bayer AG, Koninklijke Philips N.V., Bracco, and Medsquare SAS. These businesses also are working on strategic partnerships, launching new products, and increasing into new markets to growth their marketplace percentage within the coming years.
In September 2023, Qaelum NV partnered with I-MED Radiology Network to enlarge the reach of DOSE and FOQA within the ANZ area.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2017-2030
Base Year 2022
Forecast Period 2023-2030
Historical Period 2017-2021
Growth Rate CAGR of 14.2% from 2023 to 2030
Unit Value (USD Million)
Segmentation By Procedure
Computed Tomography
Nuclear Medicine
Radiography and Mammography
Fluoroscopy and Interventional Imaging
Others
By Application
Oncology
Orthopedics
Cardiology
Neurology
Others
By End-user
Hospitals & Specialty Clinics
Diagnostic Centers
Others
By Geography
North America (By Procedure, By Application, By End-user, and By Country)
U.S.
Canada
Europe (By Procedure, By Application, By End-user, and By Country/Sub-region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Procedure, By Application, By End-user, and By Country/Sub-region)
China
India
Japan
Australia
Southeast Asia
Rest of Asia Pacific
Rest of the World (By Procedure, By Application, and By End-user)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.